INTRODUCTION
The serum lipases, lipoprotein lipase (LPL) [1, 2] and hepatic lipase (HL) [3, 4] are members of the triacylglycerol (TAG) lipase gene family. They play a central role in lipid and lipoprotein metabolism, catalysing the hydrolysis of lipoprotein-associated lipids, thus modulating lipoprotein composition and plasma concentrations. LPL deficiency is associated with severe hypertriglyceridemia in humans [5, 6] and LPL knock-out mice [7, 8] . In contrast with LPL, HL deficiency in humans is associated with elevated levels of remnant lipoproteins [9] and large high-density lipoprotein (HDL) particles [10] . In addition to their function as lipolytic enzymes, LPL and HL serve as ligands that mediate the uptake of lipoproteins or lipoprotein lipids by facilitating the lipoprotein interaction with cell surface proteoglycans and receptors [11] [12] [13] [14] [15] [16] .
Endothelial-derived lipase (EDL) is a new member of the TAG lipase gene family [17, 18] . Overexpression of EDL in the liver of mice by intravenous injection of a recombinant EDLadenovirus resulted in dramatically reduced HDL-cholesterol and apolipoprotein A-I plasma levels, suggesting a role for EDL in HDL metabolism [18] . We have recently reported [19] that EDL facilitates HDL binding and particle uptake, as well as selective uptake of HDL-associated cholesterol esters (CE) by HepG2 cells, independent of its enzymic activity.
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EDL is a serum lipase, which like LPL and HL, is anchored via the heparin-binding site [20] [21] [22] to heparan sulphate proteoglycans on the luminal endothelial surface. In contrast with LPL and HL, EDL is a phospholipase with very little TAG lipase activity [23] . Owing to its predominant phospholipase activity [23] , EDL hydrolyses HDL-associated phospholipids (HDL-PL), thus generating non-esterified acids (NEFA), which might be taken up by EDL-expressing cells.
The aim of the present study was to assess the ability of EDL to supply HepG2 cells with NEFA liberated by its phospholipase activity from HDL-PL. Furthermore, we evaluated the effect of EDL overexpression on the cellular lipid composition and endogenous fatty acid (FA) synthesis in HepG2 cells.
EXPERIMENTAL

Recombinant adenovirus and plasmids
The construction of the recombinant adenoviruses used in this study coding for the human EDL (EDL-Ad), the catalytically inactive EDL (MUT-EDL-Ad) and the control β-galactosidaseexpressing adenovirus (LacZ-Ad) have been described previously [19] . For transient transfection experiments, the human EDL cDNA was cloned into the expression plasmid pBK-CMV (Stratagene) cut with BamHI and KpnI [19] . The resulting plasmid was called pBK-CMV-EDL. Plasmid HisMax-CD36, harbouring CD36 cDNA, was cloned in-frame with the coding sequence for His residues into plasmid HisMax (Invitrogen ; provided by Dr. Karina Preiss-Landl, Institute of Molecular Biology, Biochemistry and Microbiology, University of Graz, Austria.)
Cell culture, recombinant adenovirus infection and transient transfection
Cells were cultured under standard conditions (37 • C, 5 % CO 2 and 95 % humidity). HepG2 cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal calf serum (FCS), non-essential amino acids and sodium pyruvate. Human embryonic kidney cells (HEK-293) were cultured in DMEM containing 10 % FCS. HepG2 were trypsinized, counted and seeded into 24-well trays (2 × 10 5 cells/well) 48 h before experiments were performed. Cells were infected 24 h later with a multiplicity of infection (MOI, i.e. the number of viable virus particles applied per cell) of recombinant adenovirus, as indicated in each experiment. The cells were infected in culture medium containing 2 % FCS for 60 min at 37
• C. Upon infection, fresh medium with 10 % FCS was added to the cells. For some experiments, HEK-293 cells were plated into 24-well plates (5 × 10 5 cells/well) and transiently transfected by calcium phosphate co-precipitation [24] with 6 µg of pBK-CMV (control), pBK-CMV-EDL and pBK-CMV (3 µg of each), HisMax-CD36 and pBK-CMV (3 µg of each) and pBK-CMV-EDL and HisMax-CD36 (3 µg of each). Cell culture studies were performed 24 h after infection or transfection.
Western blot analysis
Western blot was performed essentially as described previously [19] . Briefly, cells were washed with PBS, collected with a hot loading buffer [20 % (w/v) glycerol, 5 % (w/v) SDS, 0.15 % (w/v) Bromophenol Blue, 63 mmol/l Tris/HCl, pH 6.8] and boiled for 10 min before loading. The cell-lysate aliquots were fractionated by SDS/PAGE (12 % polyacrylamide gels) for 1.5 h at 150 V, blotted on to nitrocellulose, followed by the detection of the EDL bands using our anti-EDL antibody, described previously [19] , and a horseradish peroxidase (HRP)-labelled mouse anti-rabbit antiserum as a second antibody. The bands were visualized using an enhanced chemiluminescent substrate for HRP (SuperSignal, Pierce, Rockford, IL, U.S.A.). To analyse the cell-surface-bound EDL, cells were washed with PBS and afterwards incubated with DMEM and heparin (2 units/ml). The heparin-releasable EDL fractions were mixed 1 : 1 (v/v) with loading buffer, incubated for 10 min at 95
• C and analysed as described for cell lysates.
Isolation and characterization of human HDL
HDL was isolated from normolipidaemic human plasma by sequential ultracentrifugation as described previously [25] . Protein concentrations were measured by the method of Lowry [26] using BSA as a standard. Total cholesterol was determined using an enzymic procedure (CHOD-PAP, Boehringer Mannheim).
Lipoprotein labelling procedure
Labelling of HDL with [
14 C]dipalmitoyl-phosphatidylcholine (NEN, Boston, MA, U.S.A.) was performed as follows : 2 µCi of [
14 C]dipalmitoyl-phosphatidylcholine (PC) was dried under nitrogen and then incubated with 1 ml of HDL (60 mg of total cholesterol/ml). The incubation was performed under nitrogen at 37
• C for 15 h in the dark. HDL was separated from the labelling mixture by exclusion chromatography using PD10 columns (Pharmacia). To confirm incorporation of the label into the PL fraction of HDL, the radiolabelled HDL was further subjected to ultracentrifugation, followed by extraction with hexane/isopropanol (3 : 2, v/v) and TLC analysis with CHCl 3 /MeOH/CH 3 COOH : H 2 O (50 : 30 : 8 : 4, by vol.) to separate the PL. Subsequent exposure to a 14 C-screen and visualization on the STORM imager revealed 14 C-PC as the radioactive component of the labelled HDL. The protein content of 14 C-HDL-derived PC (HDL-PC) was determined and the appropriate amount was used for the experiments. Labelled lipoproteins were stored at 4
• C under argon atmosphere and used within 1 week.
TLC analysis of 14 C-lipids in cell supernatants and cells expressing EDL, MUT-EDL and LacZ
HepG2 cells were seeded into 24-well trays and infected with LacZ-Ad, EDL-Ad or MUT-EDL-Ad, each at an MOI of 60, as described above. HEK-293 cells were also seeded into 24-well trays and transiently transfected as described above. At 24 h postinfection/transfection, the medium was aspirated and the cells were incubated with the indicated concentrations of 14 C-HDL-PC in DMEM containing 3 % BSA at 37
• C under cell culture conditions. After incubation (time indicated in each experiment) the supernatant was collected and the cells were incubated with DMEM containing 100 units/ml heparin to remove 14 C-HDL-PC bound to the cell surface via EDL. Afterwards, cells were washed extensively with PBS. The lipids were extracted twice from the supernatant and cells with hexane/isopropanol (3 : 2, v/v), dried in the speed vac and redissolved in chloroform before they were applied on to TLC plastic sheets. Hexane/isopropanol/CH 3 COOH (70 : 29 : 1, by vol.) was used as the mobile phase. The lipids were visualized with I 2 , and lipid spots were cut out of the TLC plate, mixed into a scintillation cocktail and measured in the β-counter. The cellular protein content was measured by the method of Bradford [26a] .
Phospholipase activity assay
The assay was done exactly as described previously [19] . PC substrate was made by mixing [
14 C]dipalmitoyl-PC (NEN), lecithin (1 mg/ml) and substrate buffer Tris/TCNB [100 mM Tris/HCl, pH 7.4, 1 % (v/v) Triton X-100, 5 mM CaCl 2 , 200 mM NaCl, 0.1 % (w/v) FA-free BSA] and subsequently dried under nitrogen. The dried PL was reconstituted in the substrate buffer. To determine EDL-phospholipase activity in the cell supernatants from EDL-overexpressing and control cells, 190 µl of the cell supernatants was added to the substrate and incubated at 37
• C for 1 h. The reaction was terminated by addition of 1 ml of 0.2 M HCl and extraction with hexane/isopropanol (3 : 2, v/v, 0.1 % HCl). Portions (500 µl) of the upper phase were dried in a speed vac and reconstituted in 100 µl of hexane/isopropanol (3 : 2, v/v). After separation by TLC (hexane/diethyl ether/acetic acid, 70 : 29 : 1, by vol.) the liberated 14 C-NEFA were quantitated in a scintillation counter (Beckman). In order to determine the capacity of the MUT-EDL to hydrolyse the ester bonds in the HDL-associated 14 C-PC, HepG2 cells were infected with EDL-Ad, MUT-EDL-Ad or LacZ-Ad, each at an MOI 60. After 48 h, cells were washed with PBS and incubated with DMEM containing 2 units/ml heparin at 37
• C for 30 min. Aliquots of 190 µl of the heparin-releasable fraction were used for the assay. C-PC-labelled HDL was used as a substrate and incubated for 1 h at 37
• C with 190 µl of the heparin-releasable fraction, and the assay was performed exactly as described above. The released 14 C-FA were separated by TLC and quantified in a scintillation counter. Total cellular protein was measured by the method of Bradford. The results represent means + − S.D. of two independent experiments performed in duplicate dishes.
Determination of PL and TAG content of the cells by quadrupole MS (Q-MS)
HepG2 cells were seeded into 24-well trays and infected with LacZ-Ad, EL-Ad or MUT-EDL-Ad, each at an MOI of 60, as described above. At 24 h post-infection, the medium was aspirated, and the cells were incubated for a further 24 h with DMEM containing 10 % FCS. After incubation, the medium was aspirated, heparin release was performed, cells were washed extensively with 1 × PBS and lipids were extracted twice with hexane/isopropanol (3 : 2, v/v). Cells were dissolved in 0.5 ml of 0.2 M NaOH and aliquots were assayed for protein by the method of Lowry et al. [26] . Aliquots of the lipid extracts corresponding to identical amounts of the total cell protein were dried in the speed vac and redissolved in chloroform for the Q-MS determination.
Quantification of mRNA by reverse transcriptase (RT)-PCR
The relative amounts of mRNAs encoding human fatty acid synthase (FAS) and β-actin were measured by sequential RT-PCR. Total RNAs from LacZ-Ad-and EDL-Ad-infected HepG2 cells were extracted using the Qiagen RNeasy system (Qiagen, Vienna, Austria) according to the manufacturer's instructions. Total RNA (1.5 µg) was treated with RQ1 RNase-free DNase I (Promega, Mannheim, Germany) for 15 min at 37
• C and subsequently used as a template for first-strand cDNA synthesis in a 30 µl reaction. The reaction mix contained 0.5 mM dNTPs (Pharmacia, Vienna, Austria), 15 units of RNAguard (Pharmacia), 3.3 µM random hexamer primers (Pharmacia), 10 mM dithiothreitol (Life Technologies, Vienna, Austria), 1 × First Strand Buffer (Life Technologies) and 200 units of Moloney murine leukemia virus reverse transcriptase (Life Technologies). Reactions were incubated for 1 h at 37
• C, heated to 75
• C for 10 min, and 2.5 µl of the completed reactions were used as template for PCR. PCR amplifications for FAS and β-actin were performed in parallel reactions. Gene-specific oligonucleotide primers based on sequences published in GenBank R human DNA database were purchased from MWG-Biotech (Ebersberg, Germany). The primer sequences were as follows : for FAS, forward primer, 5 -AGCTGCCAGAGTCGGAGAACTTG-3 (nucleotides 35-57), and reverse primer, 5 -CAAGAACTG-CACGGAGGTGTTGG-3 (nucleotides 580-603) ; and for β-actin, forward primer, 5 -GCAAGAGAGGCATCCTCACC-3 , and reverse primer, 5 -GCACAGCCTGGATAGCAACG-3 . PCR mixtures of 50 µl contained 0.2 mM dNTPs, appropriate oligonucleotide primers at 10 µM, 1 × PCR buffer (Finnzymes Oy, Vienna, Austria) and 1 unit of Finnzyme DyNAzyme II DNA polymerase (Finnzymes Oy). The reaction mix was heated to 94
• C for 4 min, and subsequently amplification was carried out for 30 cycles (or 26 cycles in the case of β-actin): denaturation, 30 s at 94
• C, annealing, 30 s at 60
• C and extension, 1 min at 72
• C. PCR products (15-20 µl) were separated by electrophoresis through 2 % agarose at 80 V for 60 min in Tris/acetate/ EDTA (TAE) buffer containing 0.05 µl/ml ethidium bromide (10 mg/ml). The relative amounts of mRNA were determined visually by densitometric scanning of gels using the E.A.S.Y. Win32 photo-documentation system (Herolab, Germany).
Measurement of FA synthesis
HepG2 cells (5 × 10 6 cells/plate) were seeded into 100 mm plates and infected with LacZ-Ad or EDL-Ad, each at an MOI of 60. After infection, each plate was incubated with 6 ml of DMEM plus 10 % FCS supplemented with 3 H 2 O (1 mCi). At 24 h post-infection, medium was collected and cells were washed with PBS. Lipids were extracted from the medium and cells using hexane/isopropanol (3 : 2, v/v) as described above, and lipid-depleted cells were used for protein measurement. Dried lipid extracts were mixed with ethanolic KOH solution (final concentration 10 %) and incubated for 1 h at 70
• C [27] . Afterwards, the mixture was extracted 3 times with hexane to remove non-saponifiable lipids. The water phase was acidified with 6 M HCl and extracted three times with hexane/diethyl ether (1 : 1, v/v). The extract containing 3 H-FA was washed with water to remove glycerol and water soluble compounds. After drying over solid Na 2 SO 4 , radioactivity of the extract containing 3 H-FA was determined by scintillation counting. The 3 H-FA from the cell supernatant was obtained using the same method.
Statistics
Data are expressed as means + − S.D. Significance of differences was examined using Student's t test. Our previous experiments have shown that EDL releases 14 C-NEFA from 14 C-HDL-PC very efficiently [19] . To examine the ability of EDL to supply cells with NEFA released from HDL-PL, cells were infected with EDL-Ad or LacZ-Ad, each at an MOI of 60, in parallel dishes and incubated with 14 C-HDL-PC for 8 h. The TLC analysis of the cellular lipids revealed that EDL-Ad infection led to a profound increase in 14 C-lipids in HepG2 cells. The amount of 14 C-PL was increased 1.6-fold and that of 14 C-TAG 2-fold compared with LacZ-Ad-infected cells (Figure 2 ). In contrast with PL and TAG in both types of cells, low percentages of label were associated with diacylglycerol (DAG), NEFA and CE fractions (results not shown). From these results it appeared that 14 C-NEFA liberated from 14 C-HDL-PC by EDL were taken up by cells and incorporated efficiently into PL and TAG. Since 14 C-HDL-PC could also be imported into HepG2 cells as a consequence of the HDL particle uptake [19] and selective uptake of HDL-PL [28] , processes that might be enhanced by EDL bridging function, we next tested the contribution of the non-enzymic function of EDL to the accumulation of 14 C-lipids in HepG2 cells.
RESULTS
EDL expression in
For these experiments we employed MUT-EDL-Ad, an adenovirus encoding catalytically inactive EDL [19] . First, we tested the capability of MUT-EDL to hydrolyse the ester bonds in the HDL-associated 14 Figure 3A) . The increase was most pronounced in the supernatant of EDL-Ad-infected cells. The TLC analysis of the cell extracts showed that EDL-Ad-infected cells accumulated profoundly higher amounts of both 14 C-TAG and 14 C-PL compared with MUT-EDL-Ad-and LacZ-Ad-infected cells ( Figures 3B and 3C ). The amount of 14 C-TAG was similar in MUT-EDL-Ad-and LacZ-Ad-infected cells ( Figure 3B ). Importantly, MUT-EDL-Ad-infected cells contained significantly higher amounts of 14 C-PL than did LacZ-Ad-infected cells ( Figure 3C ). From these results, we concluded that the accumulation of 14 C-lipids in EDL overexpressing HepG2 cells was mainly due to the EDL-mediated release of 14 C-NEFA from 14 C-HDL-PC and their subsequent incorporation into newly synthesized lipids. The fact that MUT-EDL-Ad-infected cells contained significantly higher amounts of 14 C-PL than LacZ-Adinfected cells indicated that the non-enzymic function ('bridging function') of EDL is in part responsible for the increase in 14 C-PL in EDL-infected cells.
To further confirm that EDL overexpression leads to cellular accumulation of PL and TAG as revealed in experiments with 14 Clabelled HDL, we performed the Q-MS analysis of the cellular lipids extracted from EDL-Ad-, MUT-EDL-Ad-and LacZ-Ad- s are so small that they are within the symbols) from two independent experiments performed in duplicate dishes. ***, P 0.001 (compared with LacZ) ; **, P 0.01 (compared with LacZ) ; *, P 0.05 (compared with LacZ).
followed by the TLC analysis of cellular lipids. As shown in Figures 5(A) and 5(B) , EDL-overexpressing cells contained a 1.5-fold higher amount of 14 C-PL and a 2-fold higher amount of 14 C-TAG compared with mock-transfected cells. Co-expression of CD36 and EDL led to an additive 1.4-fold increase in the amounts of 14 C-PL and 14 C-TAG respectively, compared with EDL-overexpressing cells (Figures 5A and 5B) .
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Figure 4 Determination of PL and TAG content of HepG2 cells infected with (A) EDL-Ad, (B) MUT-EDL-Ad and (C) LacZ-Ad by Q-MS
HepG2 cells were plated on to 24-well trays and infected with EDL-Ad, MUT-EDL-Ad or LacZAd (each at an MOI of 60) and incubated for 48 h in DMEM containing 10 % (v/v) FCS. After incubation, cell supernatant was aspirated, and cells were washed with DMEM containing 100 units/ml heparin for 30 min at 37 • C. After extensive washing with PBS, lipids were extracted as described in the legends for Figures 1 and 2 . Aliquots of the lipid extracts corresponding to identical amounts of the total cell protein, determined as described in the Experimental section, were dried in the speed vac and redissolved in chloroform for the Q-MS analysis. Results for each type of infection represent relative amounts of PL and TAG in the pooled samples from three wells from one of two representative experiments. Identified peaks representing PC and TAG in (A), (B) and (C) are presented in the Table. Taking into account the ability of EDL to supply cells with NEFA, including polyunsaturated fatty acids (PUFA) derived from HDL-PL [30] and the capacity of PUFA to suppress the expression of genes encoding enzymes involved in lipid synthesis [31] , we hypothesized that EDL overexpression might affect FA synthesis in HepG2 cells. To address this, we first analysed the abundance of FAS mRNA in HepG2 cells infected with EDLAd or LacZ-Ad by RT-PCR. Results presented in Figure 6 show that EDL overexpression led to a 2-fold (at an MOI of 30) and 2. 
DISCUSSION
EDL is a member of the TAG lipase gene family [17, 18] . Adenovirus-mediated EDL overexpression in mice dramatically reduced HDL and apoliprotein A-I plasma levels [17] . Cell culture experiments showed that EDL very efficiently mediates HDL particle binding and uptake, as well as selective uptake of HDL-associated CE, independent of its enzymic activity [19] . Additionally, it has been demonstrated that EDL very efficiently releases NEFA from HDL-PL [19, 23] . In the present study, we aimed to assess the ability of EDL to supply NEFA derived from HDL-PL to cells and to determine the effect of liberated NEFA on the cellular lipid composition and FA synthesis. For these purposes, we expressed human EDL in HepG2 cells and HEK-293 cells by a recombinant adenovirus or transient transfection approach. In both EDL-overexpressing cell types, EDL was detected in the cell lysate, on the cell surface bound to the heparin sulphate proteoglycans and in the cell medium. EDL overexpression in HepG2 cells led to a pronounced increase in the amounts of 14 C-PL and 14 C-TAG upon incubation with 14 C-HDL-PC labelled in the FA moiety. From this finding we concluded that 14 C-NEFA derived from 14 C-HDL-PC by EDL phospholipase activity are taken up by cells and incorporated into newly synthesized lipids. These results are in line with a previous study, demonstrating that the capacity of HepG2 cells for PL and TAG synthesis from exogenously derived FA was higher than from endogenously synthesized FA [32] . The low amount of 14 C-NEFA in the cell lysates of both LacZ-Ad-and EDL-Adinfected cells might be explained by the fact that [
14 C]palmitic acid released from labelled HDL-PC represents a preferential substrate for the acyl transferases which catalyse its rapid incorporation into endogenous PL and TAG [33] . The low amount of 14 C-DAG detected in EDL-Ad-infected cells upon incubation with the 14 C-HDL-PC is most probably due to a rapid conversion of DAG into TAG owing to the high rate of the TAG synthesis in HepG2 cells. The fact that acyl CoA :cholesterol acyltransferase 1 (ACAT1) in HepG2 cells utilizes preferentially oleoyl-and linolenoyl-CoA as substrates for cholesterol esterification [34] might conceivably explain the low amount of 14 C-CE in HepG2 cells incubated with the 14 C-HDL-PC. To assess whether the effect of EDL is dependent only on its enzymic function, we employed an adenovirus encoding the enzymically inactive EDL. The finding that cells expressing enzymically inactive EDL accumulated profoundly lower amounts of 14 C-PL and 14 C-TAG than cells expressing enzymically active EDL confirmed that the effect of EDL on the accumulation of 14 C-lipids is strongly dependent on EDL enzymic activity. However, the amount of 14 C-PL was significantly higher in cells expressing mutant EDL compared with control cells. This finding indicated that EDL has the ability to enhance the uptake of 14 C-HDL-PC by HepG2 cells independent of its enzymic activity. One possible explanation for this finding could be that enzymically inactive EDL anchors HDL to the cell surface [19] , thus facilitating the scavenger receptor class B Type I (SR-BI) [35, 36] -mediated selective import of the lipoprotein-associated PL into cells [28] . Accordingly, 14 C-PL in HepG2 cells that express enzymically active EDL represent a mixture of both endogenously synthesized 14 C-PL containing 14 C-NEFA released from 14 C-HDL-PC by EDL phospholipase activity and 14 C-PC taken up from 14 C-HDL-PC, mediated by the non-enzymic (bridging) function of EDL. Results obtained from experiments with 14 C-labelled HDL could further be confirmed by Q-MS analysis of cellular lipids obtained from EDL-Ad-, MUT-EDL-Ad-and LacZ-Ad-infected HepG2 cells. These experiments again showed that the highest amounts of PL and TAG were found in cells expressing enzymically active EDL. Importantly, cells expressing enzymically inactive EDL contained more PL than LacZ-Ad-infected control cells. To examine a possible impact of CD36 on EDL action, we performed co-expression experiments (EDL plus CD36), which clearly demonstrated that CD36 expression augmented EDL-mediated accumulation of 14 C-PL and 14 C-TAG in HEK-293 cells. This augmenting effect of CD36 might be ascribed to its role as a FA translocase [29] . Accordingly, NEFA released from HDL-PL by EDL phospholipase activity could be imported into cells expressing CD36 more efficiently, in addition to EDL. Alternatively, or additionally, due to its high affinity for HDL [37] , CD36 might concentrate HDL on the cell surface thus supplying it to EDL for cleavage. Considering the ability of EDL to supply cells with FA, including PUFA [30] , and the fact that PUFA suppress the expression of lipogenic genes, including FAS [31] , a central enzyme in the de novo lipogenesis, via down-regulation of sterol regulatory element binding protein-1 (SREBP-1) [38] [39] [40] [41] [42] [43] , we assumed that EDL expression might have an impact on FA synthesis in HepG2 cells. Our assumption was confirmed by the finding that the amount of FAS mRNA, as well as the rate of FA synthesis, were decreased in EDL-expressing cells compared with controls. Additionally, these observed effects of EDL overexpression might be due to a PUFA-mediated suppression of the FAS promoter activity in HepG2 cells [44] .
Taken together, our results demonstrate that EDL efficiently cleaves NEFA from HDL-PL, supplying NEFA for HepG2 cells, where they are incorporated into endogenous lipids, leading to an increase in the amounts of PL and TAG. This effect of EDL could be augmented by EDL/CD36 co-expression in HEK-293 cells. By its non-enzymic function, EDL enhances the uptake of HDL-PL in HepG2 cells. Additionally, the overexpression of EDL in HepG2 cells lowers the amount of FAS mRNA and the rate of FA synthesis.
